EUVIMEDEUVIMED entdecken
Crossref

Simulation-Free Adaptive Prostate Stereotactic Body Radiation Therapy on Magnetic Resonance-Linac: Technical Feasibility and Clinical Experience

Nicolas Côté, Lian Sun, Himanshu Nagar, Victoria Brennan, Ching-Yun Chan, Gabrielle Maggia, James Mechalakos, Eric Aliotta, Victoria Yu, Arthur Lalonde, Neelam Tyagi

International Journal of Radiation Oncology*Biology*Physics · 2026-10 · 126 (2) · 533-543

DOI: 10.1016/j.ijrobp.2026.03.031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-10. Verfasst von Nicolas Côté und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Physics, Université de Montréal, Montréal, Q…. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Radiosurgery, Magnetic Resonance Imaging, Radiotherapy Planning, Computer-Assisted. Die Arbeit nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To develop and evaluate 2 simulation-free (SF) stereotactic body radiation therapy (SBRT) workflows for prostate cancer on magnetic resonance (MR)-Linac: one using a diagnostic MR reference scan and another using a preapproved template scan. METHODS AND MATERIALS: Population-based relative electron density (RED) values were derived from 100 prostate SBRT patients on the Elekta Unity MR-Linac and validated on a separate cohort of 10 patients for dosimetric equivalence. Two SF approaches were evaluated in another independent cohort of 10 patients using reference plans derived from: (1) a diagnostic MR scan (5 retrospective, 5 prospective), and (2) a digitally created pelvic phantom scan using population-based RED (all retrospective). The performance of artificial intelligence-generated contours was investigated during adaptive treatments using surface Dice (sDSC) with 1 mm tolerance and added path length. All adaptive plans, from both SF and the clinically delivered workflow, were compared in terms of dose metrics and monitor unit usage. A focused failure modes and effects analysis identified and mitigated diagnostic MR SF-specific risks by calculating the risk priority number (RPN). RESULTS: Population-based RED assignments resulted in mean dose differences under 1%. Artificial intelligence contours showed strong agreement with physician-approved contours, with sDSC and added path length of 0.96/26.2cm,0.98/17.2cm,0.99/0.4cm, and 0.99/0.01cm for bladder, rectum, penile bulb, and bone, respectively. Across both SF workflows, adaptive plans were clinically comparable to the standard workflow, with mean dose differences from -1.7% to 4.6% and mean monitor unit differences remaining under 2%. Failure modes and effects analysis identified 3 high-risk failure modes: mislabeling diagnostic MR scans (RPN=39), case tracking lapses (RPN=29), and incorrect RED assignment (RPN=22), all mitigated through workflow refinements and training. The diagnostic MR SF workflow has been clinically implemented, treating 22 patients without failures. CONCLUSIONS: Both SF workflows eliminated the need for simulation, streamlining adaptive prostate SBRT without compromising plan quality. The template-based workflow further improved patient access by removing imaging prerequisites.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsRadiosurgeryMagnetic Resonance ImagingRadiotherapy Planning, Computer-AssistedHumansMaleFeasibility StudiesRetrospective StudiesPhantoms, ImagingWorkflowOrgans at RiskProspective StudiesRadiotherapy DosageArtificial IntelligenceRectumUrinary Bladder

Autor:innen und Institutionen

  • Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Physics, Université de Montréal, Montréal, Quebec, Canada. Electronic address: coten@mskcc.org.
  • Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Department of Physics, Université de Montréal, Montréal, Quebec, Canada.

Zitieren

APA

Côté, N., Sun, L., Nagar, H., Brennan, V., Chan, C. Y., Maggia, G., Mechalakos, J., Aliotta, E., Yu, V., Lalonde, A., & Tyagi, N. (2026). Simulation-Free Adaptive Prostate Stereotactic Body Radiation Therapy on Magnetic Resonance-Linac: Technical Feasibility and Clinical Experience. International Journal of Radiation Oncology*Biology*Physics, 126(2), 533-543. https://doi.org/10.1016/j.ijrobp.2026.03.031

Vancouver

Côté N, Sun L, Nagar H, Brennan V, Chan CY, Maggia G, et al. Simulation-Free Adaptive Prostate Stereotactic Body Radiation Therapy on Magnetic Resonance-Linac: Technical Feasibility and Clinical Experience. International Journal of Radiation Oncology*Biology*Physics. 2026;126(2):533-543. doi:10.1016/j.ijrobp.2026.03.031

BibTeX
@article{Ct2026,
  author = {Côté, Nicolas and Sun, Lian and Nagar, Himanshu and Brennan, Victoria and Chan, Ching-Yun and Maggia, Gabrielle and Mechalakos, James and Aliotta, Eric and Yu, Victoria and Lalonde, Arthur and Tyagi, Neelam},
  title = {Simulation-Free Adaptive Prostate Stereotactic Body Radiation Therapy on Magnetic Resonance-Linac: Technical Feasibility and Clinical Experience},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  year = {2026},
  volume = {126},
  number = {2},
  pages = {533--543},
  doi = {10.1016/j.ijrobp.2026.03.031}
}
Kostenlos starten →